Taysha Gene Therapies Stock: Rett Data Checks Momentum,Road Ahead Rocky (NASDAQ:TSHA) | Old North State Wealth News
Connect with us

Investing

Taysha Gene Therapies Stock: Rett Data Checks Momentum,Road Ahead Rocky (NASDAQ:TSHA)

Published

on

Klaus Vedfelt/DigitalVision via Getty Images

Investment Overview

Taysha Gene Therapies (NASDAQ:TSHA) stock hit the skids yesterday as the Dallas, Texas headquartered biotech reported data from its Phase 1/2 REVEAL study of its lead and only gene therapy TSHA-102 in10K submission

Read the full article here

Advertisement

Trending

Copyright © 2024 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.